Psychedelics Sector Update: Biopharma Co. Makes Major Headway Toward Clinical Trials for Treatment of Stroke
Finding an effective method of preventing the possibility of stroke is something that medical science has grappled with for decades. Now, a Vancouver-based clinical stage biopharmaceutical development company looks to be making significant headway by repurposing a known psychedelic compound that is part of the tryptamine family to help battle stroke. Stockhouse Media's Dave Jackson reports.
Read the Full Story Here
Weekly Update - Top Cannabis News Stories
1 | Top Story: Delta 9 Cannabis Inc. provides guidance & timing for Q2 2021 results.
2 | Affinor Growers Inc. files patent for modular nitrogen enriched drying & curing vessels.
3 | The Valens Company Inc. completes acquisition of leading US CBD company
4 | SpeakEasy Cannabis Club Ltd. announces start of 2021 planting season.
5 | Pure Extracts Technologies and Canada House Wellness Group sign supply agreement for medicinal cannabis products.
Top Cannabis Stocks - June 17 to June 23, 2021
1. T.HEXO | 25,975 views | HEXO Corp.
2. T.WEED | 17,376 views |Canopy Growth Corporation.
3. TLRY | 17,181 views | Tilray Inc.
4. C.CBDT | 11,051 views | Empower Clinics Inc.
5. T.TBP | 10,863 views | Tetra Bio-Pharma Inc.
6. C.TNY | 9,482 views | Tinley Beverage Co Inc.
FULL DISCLOSURE: Algernon Pharmaceuticals Inc., Delta 9 Cannabis Inc., and Affinor Growers are clients of Stockhouse Publishing.
New to investing in Cannabis? Check out Stockhouse tips on How to Invest in Cannabis Stocks and some of our Top Cannabis Stocks.
For more of the latest info on Cannabis, check out the Cannabis Trending News hub on Stockhouse.